Journal: Bioengineered
Article Title: Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis
doi: 10.1080/21655979.2022.2048992
Figure Lengend Snippet: HUR regulated MAPKAPK3 expression and cell proliferation and mobility . U251 and U87 cells were treated with the NC siRNA + vector, HUR siRNA + vector, and HUR siRNA + MAPKAPK3 overexpression plasmid (MAPKAPK3-OE). (a–b) Western blotting was used to detect the protein expression of HUR, MAPKAPK3, p-MAPKAPK3, and p-CREB in each group. (c) The CCK-8 assay was used to detect the cell viability in each group in 48 h. (d-e) Transwell assays were used to detect the invasive cell numbers in each field in each group. (f–g) Western blotting was used to detect the expression of MAPKAPK3 in TSPO knockdown cells with HUR overexpression. (h) Amanitin (0.1 µM) was used to inhibit the mRNA synthesis for 0, 2, 4, 6, and 8 h, and qRT-PCR results indicated that overexpression of HUR increased the mRNA stability of MAPKAPK3 in U87 and U251 cells with TSPO inhibition. * P < 0.05; ** P < 0.01.
Article Snippet: The plasmids overexpressing MAPKAPK3 and HUR were obtained from Juneng Huida Biological Co., Ltd. (Wuhan, China).
Techniques: Expressing, Plasmid Preparation, Over Expression, Western Blot, CCK-8 Assay, Knockdown, Quantitative RT-PCR, Inhibition